Digest Network Come funziona
Network
/
Società
Ni
Non verificato

Niagen Bioscience, Inc

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteScienzaWeb e Social Network

56 comunicati stampa

Guarda tutti i comunicati
10/09/2026
Eventi
Web e Social Network
Fitness
Accessori
Biotecnologia
Salute
Farmaceutica
Sanità
Pubblico Esercizio/Vendita al dettaglio
E-commerce
Niagen Bioscience to Present at Canaccord Genuity’s Well Summit
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
02/09/2026
Eventi
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience to Present at Longevity Investors Conference
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
26/08/2026
Eventi
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
20/08/2026
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
06/08/2026
Industria
Sanità
E-commerce
Grande distribuzione
Vetrine/Shopping
Fitness
Pubblico Esercizio/Vendita al dettaglio
Terza età
Salute
Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
03/08/2026
Mercato del lavoro
Industria
Scienza
Terza età
Infanzia
Biotecnologia
Medicina - Varie
Farmaceutica
Vetrine/Shopping
Salute
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
28/07/2026
Industria
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biological Aging
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
27/07/2026
Eventi
Web e Social Network
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
21/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
13/07/2026
Industria
Salute
Igiene alimentare
Vetrine/Shopping
Infanzia
Sanità
Farmaceutica
Biotecnologia
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0